Table 2.
Effect of characteristics of patients on improvement rate of cognitive state.
| Statistics | OR (95% CI) p-Value | |
|---|---|---|
| Age | 59.01 ± 8.03 | 1.06 (1.00, 1.11) 0.0362 |
| Gender | ||
| male | 63 (61.17%) | 1.0 |
| female | 40 (38.83%) | 1.34 (0.61, 2.98) 0.4657 |
| Education (years) | 5.54 ± 4.38 | 1.42 (1.23, 1.63) <0.0001 |
| LED | 659.95 ± 363.80 | 1.00 (1.00, 1.00) 0.9761 |
| UPDRSIII drug off | 54.00 ± 14.15 | 1.04 (1.01, 1.07) 0.0090 |
| UPDRSIII drug on | 26.64 ± 11.47 | 1.08 (1.03, 1.12) 0.0005 |
| Drug improvement rate | 0.52 ± 0.14 | 0.04 (0.00, 0.79) 0.0339 |
| MMSE Preop | 24.99 ± 3.74 | 0.70 (0.61, 0.82) <0.0001 |
| MOCA Preop | 18.67 ± 6.15 | 0.46 (0.34, 0.64) <0.0001 |
| NMSS Preop | 87.53 ± 30.01 | 1.01 (0.99, 1.02) 0.3303 |
| PDQ39 Preop | 73.24 ± 16.25 | 1.01 (0.99, 1.04) 0.2737 |
| HAMD Preop | 15.73 ± 6.66 | 1.05 (0.99, 1.12) 0.1292 |
| HAMA Preop | 18.06 ± 5.38 | 1.04 (0.97, 1.12) 0.2726 |
| Duration (years) | 8.70 ± 3.80 | 0.98 (0.88, 1.08) 0.6637 |
| H-Y | ||
| 2 | 2 (1.94%) | 1.0 |
| 2.5 | 16 (15.53%) | 0.78 (0.04, 14.75) 0.8671 |
| 3 | 50 (48.54%) | 0.85 (0.05, 14.39) 0.9115 |
| 4 | 28 (27.18%) | 1.33 (0.08, 23.54) 0.8443 |
| 5 | 7 (6.80%) | 2.50 (0.10, 62.61) 0.5771 |